2016
DOI: 10.1186/s13073-016-0312-1
|View full text |Cite
|
Sign up to set email alerts
|

Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota

Abstract: BackgroundRoux-en-Y gastric bypass (RYGB) is an effective means to achieve sustained weight loss for morbidly obese individuals. Besides rapid weight reduction, patients achieve major improvements of insulin sensitivity and glucose homeostasis. Dysbiosis of gut microbiota has been associated with obesity and some of its co-morbidities, like type 2 diabetes, and major changes of gut microbial communities have been hypothesized to mediate part of the beneficial metabolic effects observed after RYGB. Here we desc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

39
243
1
5

Year Published

2016
2016
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 269 publications
(301 citation statements)
references
References 81 publications
39
243
1
5
Order By: Relevance
“…MGR increased only progressively and became significant 1 year after both surgeries, concordant with previous reports: (1) 8 RYGB patients showing a non-significantly increased MGR at 1 year10; (2) increased MGR 3 months postsleeve in a cohort similar in size to ours, using shotgun sequencing12; and (3) increased richness 6 months post-RYGB using 16S-pyrosequencing 50. Noteworthy, metformin, which represents the first line of diabetes treatment23 and not a marker of T2D severity, was given at baseline to most of our patients with T2D (8/9).…”
Section: Discussionsupporting
confidence: 92%
“…MGR increased only progressively and became significant 1 year after both surgeries, concordant with previous reports: (1) 8 RYGB patients showing a non-significantly increased MGR at 1 year10; (2) increased MGR 3 months postsleeve in a cohort similar in size to ours, using shotgun sequencing12; and (3) increased richness 6 months post-RYGB using 16S-pyrosequencing 50. Noteworthy, metformin, which represents the first line of diabetes treatment23 and not a marker of T2D severity, was given at baseline to most of our patients with T2D (8/9).…”
Section: Discussionsupporting
confidence: 92%
“…An attractive possibility would be a change in the amount of specific intestinal bacteria conferring metabolic benefits as Prevotella copri 2829 or Akkermansia muciniphila 30. It is noteworthy that Akkermansia muciniphila is increased after gastric bypass in morbidly obese patients3132, and that a protein from its membrane is beneficial for glucose control by itself33.…”
Section: Discussionmentioning
confidence: 99%
“…Similar gut microbial changes were seen after non-surgical weight loss [112,118]. Unlike in non-surgical weight loss, there was an increased abundance of Proteobacteria, specifically Escherichia coli, after RYGB [115][116][117][119][120][121][122][123]. Enterobacteriaceae and Pasteurellaceae were also associated with weight loss after RYGB [122,123].…”
Section: Intestinal Motility After Rygbmentioning
confidence: 54%